Featured Photo
High Quality
Safe
Professional
Specialised
-
SINO-FRENCH
JOINTVENTURE -
Dedicated to research, development and manufacturing of innovative urological medical devices, Shanghai MyoPowers Medical Technology Co., Ltd was jointly established by Shanghai Zuquan Investment Management Co., Ltd and MyoPowers Medical Technologies S.A.S, a French enterprise, in April 2018
-
CONVENIENT
GEOGRAPHICAL
POSITION -
Located in the Building 12-13 Landian Park of Shanghai International Medical Zone (SIMZ), Shanghai Pudong New Area, the Company is in the heart of a leading-edge Chinese medical cluster, with convenient geographical position, only 18 km from Shanghai Pudong Airport and 25km from Shanghai Hongqiao Airport, enjoying excellent infrastructure, intensive international exchanges and rich research and higher education resources.
The health problems that can not be ignored:
URINARY INCONTINENCE
In the context of population aging and increasing life standards, urinary incontinence has become a non neglectable health concern in the world, affecting seriously patients’ wellness and life quality, generating a heave economic burden for families and society.
As an innovative medical company in the field of muscle diseases, Shanghai MyoPowers Medical Technology Co., Ltd endeavors to develop products able to improve or replace functional muscles, including active implantable devices for treating severe urinary incontinence, with a view to helping patients to retrieve their normal life and social activities.
Professional and focused,
Shanghai MyoPowers will continuousely advance,
for more people's health.
248 million
The number of elderly population in China
The Chinese aged population is expected to reach 248 million people, by 2020, or an aging level of 17.17%, including 30.67 million inhabitants of more than 80.
3 tripled
Prevalence of severe depression
Statistics show that patients with urinary incontinence suffer from "severe depression" about 3 times that of patients with mild urinary incontinence.
29%
Incidence of adult
Data show that the incidence of urinary incontinence in China is about 29%, and the incidence of stress urinary incontinence is about 8%, and the incidence increases with age.
92%
Incidence of parturients
19% of women without urinary incontinence after primipara are incontinent in 5 years postpartum, 92% of women having urinary incontinence within 3 months after primipara continue to suffer 5 years later.
25%
Rate of treatment for urinary incontinence
At present, the treatment tendency of stress urinary incontinence in China is very low, and the healthcare of urinary incontinence in general is not ideal. Only 25% of patients with urinary incontinence go to hospital.